From various sources, including Yahoo, the WSJ and newspapers all over the country:
Trasylol - a drug made by Bayer - that has been provided to heart surgery patients so as to limit or even prevent blood loss doubles kidney failure and stroke risks according to the NEJM.
The drug also increases the chance of heart failure or heart attack by 55 percent.
The drug study involved more than 4,000 patients who were facing heart surgery at 69 medical centers around the world.
